This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., The General Hospital Corporation. Active years: 2012-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2012)
- Houston, TX (US) (2017)
Company Filing History:


Years Active: 2012-2017
Title: Innovations by Inventor Xin Lu
Introduction
Xin Lu is a prominent inventor based in Houston, Texas, known for his significant contributions to cancer research and treatment. With a total of two patents to his name, he has developed innovative methods and compositions that aim to improve cancer detection and treatment.
Latest Patents
Xin Lu's latest patents include "Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof." This invention provides compositions containing photoactivatable caged tamoxifen and tamoxifen derivative molecules. It also includes kits that contain these compositions along with a light source. Furthermore, the patent outlines methods for optically inducing nuclear translocation of a fusion protein containing a mammalian estrogen receptor ligand binding domain in a eukaryotic cell. Additionally, it describes methods for treating breast cancer by administering a photoactivatable caged tamoxifen or tamoxifen derivative molecule to a subject diagnosed with breast cancer. Another notable patent is "Fibrinogen alpha and hemoglobin polypeptides as cancer markers," which offers methods for detecting cancer using specific biomarkers.
Career Highlights
Throughout his career, Xin Lu has worked with esteemed institutions such as the Dana-Farber Cancer Institute and The General Hospital Corporation. His work has focused on developing innovative solutions for cancer treatment and detection, making a significant impact in the field of oncology.
Collaborations
Xin Lu has collaborated with notable colleagues, including Sarit S. Agasti and Ronald A. DePinho, contributing to advancements in cancer research and treatment methodologies.
Conclusion
Xin Lu's innovative work in cancer research, particularly through his patents, showcases his commitment to improving patient outcomes. His contributions continue to influence the field and inspire future research in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile